Mitsuyasu Terashima Selected Research

Mitsuyasu Terashima Research Topics

Disease

24	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 11/2002
17	Atherosclerotic Plaque (Atheroma) 09/2016 - 08/2007
9	Hyperplasia 01/2019 - 11/2005
9	Angina Pectoris 01/2015 - 11/2002
7	Thrombosis (Thrombus) 01/2022 - 12/2009
6	Pathologic Constriction (Stenosis) 12/2023 - 11/2005
6	Atherosclerosis 03/2015 - 11/2002
6	Diabetes Mellitus 05/2014 - 02/2006
5	Neointima 01/2019 - 02/2006
5	Myocardial Infarction 10/2015 - 09/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2014 - 03/2009
4	Rupture 04/2012 - 03/2009
3	Hypertension (High Blood Pressure) 09/2015 - 02/2007
3	Unstable Angina 04/2013 - 10/2005
2	Death (Near-Death Experience) 10/2015 - 05/2014
2	Stable Angina 07/2013 - 07/2009
2	Acute Coronary Syndrome 04/2013 - 12/2009
2	AIDS-Related Complex (ARC) 05/2012 - 11/2005
2	Coronary Stenosis (Coronary Artery Stenosis) 03/2012 - 02/2012
2	Coronary Vasospasm (Coronary Artery Vasospasm) 03/2012 - 02/2012
1	Arteritis 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 11/2016
1	Chronic Renal Insufficiency 11/2016
1	Hypercholesterolemia 09/2016
1	Intussusception 06/2012
1	Dyslipidemias (Dyslipidemia) 04/2012
1	Spasm (Spasms) 03/2012
1	Muscle Spasticity (Spastic) 03/2012
1	Prolapse 03/2012
1	Fibrosis (Cirrhosis) 02/2012
1	Necrosis 02/2012
1	Hypersensitivity (Allergy) 12/2009
1	Flushing 03/2008
1	Hyperlipidemias (Hyperlipidemia) 02/2007
1	Inflammation (Inflammations) 09/2006

Drug/Important Bio-Agent (IBA)

19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2016 - 07/2009
12	Sirolimus (Rapamycin)FDA Link 05/2014 - 11/2005
9	LipidsIBA 10/2018 - 07/2009
8	MetalsIBA 01/2019 - 11/2005
4	CalciumIBA 09/2013 - 11/2005
4	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2009 - 11/2002
3	omega-Chloroacetophenone (Mace)IBA 10/2015 - 03/2009
3	LDL CholesterolIBA 09/2015 - 07/2009
3	Pravastatin (Pravachol)FDA LinkGeneric 01/2015 - 06/2013
2	CholesterolIBA 09/2016 - 07/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 09/2015 - 02/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2015 - 07/2009
2	pitavastatin (itavastatin)FDA Link 01/2015 - 06/2013
2	Fluvastatin FDA Link 02/2014 - 07/2009
2	Docosahexaenoic AcidsIBA 01/2014 - 01/2013
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2013 - 01/2013
2	oxidized low density lipoproteinIBA 01/2013 - 11/2002
2	Phenobarbital (Luminal)FDA Link 03/2012 - 02/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2009 - 01/2007
1	tocilizumab (atlizumab)FDA Link 12/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023
1	Contrast MediaIBA 01/2016
1	Atenolol (Tenormin)FDA LinkGeneric 09/2015
1	pigment epithelium-derived factorIBA 03/2015
1	Uric Acid (Urate)IBA 06/2014
1	Lipoprotein(a)IBA 04/2014
1	Ezetimibe (Zetia)FDA Link 02/2014
1	Platelet Activating FactorIBA 04/2013
1	Arachidonic Acid (Vitamin F)IBA 01/2013
1	C-Reactive ProteinIBA 01/2013
1	Eicosapentaenoic AcidIBA 01/2013
1	Atorvastatin (Lipitor)FDA Link 04/2012
1	Ergonovine (Ergometrine)IBA 03/2012
1	Telmisartan (Micardis)FDA Link 02/2012
1	Ringer's LactateIBA 03/2008
1	Interleukin-6 (Interleukin 6)IBA 09/2006
1	CD40 Ligand (CD40L)IBA 09/2006
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2005
1	Oxidoreductases (Dehydrogenase)IBA 11/2002
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 11/2002
1	Superoxides (Superoxide)IBA 11/2002
1	NAD (NADH)IBA 11/2002

Therapy/Procedure

25	Stents 12/2023 - 11/2005
20	Therapeutics 09/2016 - 07/2009
10	Percutaneous Coronary Intervention 11/2016 - 02/2006
4	Drug-Eluting Stents 01/2022 - 05/2010
1	Renal Dialysis (Hemodialysis) 11/2016
1	Catheters 06/2012
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2009